Anbioton has been acquired by Elfa Medicamentos
The shareholders of Anbioton have sold the company to Elfa Medicamentos, a Patria Investimentos portfolio company.
Anbioton is focused on the Brazilian pharmaceutical distribution market. The company serves close to 1,400 private hospitals and 200 public entities through partnership agreements with more than 75 pharmaceutical companies.
Elfa Medicamentos was founded in 1989 by Edalmo Leite Fernandes Assis. The company’s operations are focused on the distribution of specialty medicines and generic and branded drugs, hospital supplies, and high value-added solutions for medical plans, clinics, hospitals, government, doctors and patients across the country.
One of Oaklins’ teams in Brazil acted as the exclusive sell-side advisor for Anbioton and its shareholders.
Talk to the deal team
Related deals
Perkbox has been acquired by Great Hill Partners
Molten Ventures has sold Perkbox to Great Hill Partners.
Learn moreArculus Cyber Security has been acquired by Bridewell
The shareholders of Arculus Cyber Security (Arculus) have sold the business to Bridewell. The deal will bolster Bridewell’s growing roster of accreditations as well as strengthen its public sector footprint, enabling the expansion of its end-to-end cyber security offering for clients across the globe.
Learn moreGlobal IT Group has joined forces with enthus Group
Global IT Group, an IT services company, and enthus Group GmbH, an IT solution provider operating in Germany, Austria and Switzerland, have joined forces. As a result, enthus Group will significantly expand its market position in Switzerland. The sellers of Global IT have reinvested in the buyer and will ensure that local management continues to run the company as part of the succession planning.
Learn more